VMED — Viromed Medical AG Income Statement
0.000.00%
- €96.39m
- €96.37m
- 13
- 12
- 87
- 26
Annual income statement for Viromed Medical AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 24 W | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS |
Status: | Final | Final | Final |
Total Revenue | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||
Other Operating Expenses | |||
Total Operating Expenses | 0.005 | 0.16 | 0.359 |
Operating Profit | -0.005 | -0.16 | -0.359 |
Total Net Non Operating Interest Income / Expense | |||
Net Income Before Taxes | -0.005 | -0.161 | -0.11 |
Net Income After Taxes | -0.005 | -0.161 | -0.11 |
Net Income Before Extraordinary Items | |||
Net Income | -0.005 | -0.161 | -0.11 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -0.005 | -0.161 | -0.11 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.02 | -0.008 | -0.005 |
Dividends per Share |